Matt McNamara - Avita Medical Director

Director

Mr. Matt McNamara was NonExecutive Director of the Company. Mr McNamara is currently the Chief Investment Officer and Fund Manager of Octa Phillip Bioscience Managers. Matt has over 23 years experience in the healthcare medical sciences sector. After initially being a molecular biology research assistant Matt spent 11 years in Sales Marketing and General Management with Merck Co. and Johnson Johnson Medical Pty. Ltd. respectively. He has served as SVP Business Development for a University of Sydney spin out eBioinformatics Inc. and was CEO of a Life Sciences VC fund SciCapital Pty. Ltd. since 2012.
Tenure 12 years
Phone661-367-9170
Webhttp://www.avitamedical.com

Avita Medical Management Efficiency

The company has return on total asset (ROA) of (72.68) % which means that it has lost $72.68 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (140.09) %, meaning that it generated substantial loss on money invested by shareholders. Avita Medical's management efficiency ratios could be used to measure how well Avita Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 99.29 K in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Avita Medical Limited has a current ratio of 5.39, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Avita Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Avita Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avita Medical Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avita to invest in growth at high rates of return. When we think about Avita Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Paul PolmanDow Inc
59
Ruth ShawDow Inc
70
Tony IsaacLive Ventures
70
James BellDow Inc
71
Edwin RyderHooker Furniture
69
Jeffrey WrightHawkins
54
Eva HowellDow Inc
69
Luis MorenoDow Inc
67
Daniel StauberHawkins
62
James ThompsonHawkins
67
Theresa WaglerCF Industries Holdings
50
William DavissonCF Industries Holdings
72
Paulette GarafoloHooker Furniture
60
Charles ThorneDow Inc
67
Teresa HandicottDow Inc
54
Edward SchmittCF Industries Holdings
69
Yang ZouGulf Resources
43
Nan LiGulf Resources
38
Mark LoughridgeDow Inc
62
Celso WhiteCF Industries Holdings
59
Greg PowellLive Ventures
N/A
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. AVITA MEDICAL operates under Medical Devices classification in USA and is traded on BATS Exchange. Avita Medical Limited [AVMXY] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Avita Medical Limited Leadership Team

Elected by the shareholders, the Avita Medical's board of directors comprises two types of representatives: Avita Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avita. The board's role is to monitor Avita Medical's management team and ensure that shareholders' interests are well served. Avita Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avita Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Damien McDonald, Non-Executive Director
Lou Panaccio, Chairman of the Board
Stella Sung, IR Officer
Jeremy Cook, Director
Ross Saunders, Vice President - Sales and Marketing
Fiona Wood, Non-Executive Director
Dale Sander, CFO
Louis Drapeau, Non-Executive Director
Lorraine Glover, General Manager of Asia Pacific
William Marshall, VP of Operations and Quality
Matt McNamara, Director
Michael Perry, Director
Suzanne Crowe, Non-Executive Director
Gabriel Chiappini, Company Secretary
Andrew Quick, VP of Research and Technology
Ian Macpherson, Non-Executive Deputy Chairman of the Board
Tim Rooney, Interim CEO
Adam Kelliher, CEO
Troy Barring, COO

Avita Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Avita Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avita Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avita Medical's short interest history, or implied volatility extrapolated from Avita Medical options trading.

Pair Trading with Avita Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avita Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avita Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Xylem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xylem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xylem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xylem Inc to buy it.
The correlation of Xylem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xylem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xylem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xylem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Avita OTC Stock

If you are still planning to invest in Avita Medical Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avita Medical's history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges